Acasă › Cancer de sân › California › San Francisco
Studii clinice pentru Cancer de sân în San Francisco, CA
43 studii pentru Cancer de sân caută participanți în și în jurul orașului San Francisco (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
În curs de recrutareFaza 1/2
- Research Site, San Francisco
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
În curs de recrutareFaza 3
- University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
În curs de recrutare
- Kaiser Permanente-San Francisco, San Francisco
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
În curs de recrutareFaza 2
- University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
În curs de recrutareFaza 3
- Clinical Trial Site, San Francisco
- Clinical Trial Site, San Francisco
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
În curs de recrutareFaza 3
- Kaiser Permanente, San Francisco
- UCSF Medical Center at Mission Bay, San Francisco
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
În curs de recrutareVoluntari sănătoși bineveniți
- University of California San Francisco, San Francisco
Pulsed Electric Field Ablation for Metastatic Breast Cancer
În curs de recrutare
- University of California San Francisco, San Francisco
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
În curs de recrutareFaza 3
- UCSF Zuckerberg SF General, San Francisco
- University of California, San Francisco (UCSF), San Francisco
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
În curs de recrutareFaza 1
- UCSF Medical Center at Mission Bay, San Francisco
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
În curs de recrutareFaza 1/2
- UCSF Helen Diller Family CCC, San Francisco
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
În curs de recrutareFaza 1/2
- University of California, San Francisco, San Francisco
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
În curs de recrutareFaza 1/2
- University of California-San Fransisco, San Francisco
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
În curs de recrutareStudiu observațional
- University of California, San Francisco, San Francisco
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
În curs de recrutareFaza 3
- California Pacific Medical Center-Pacific Campus, San Francisco
- Kaiser Permanente-San Francisco, San Francisco
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
În curs de recrutareFaza 2
- University of San Francisco, San Francisco
ATEMPT 2.0: Adjuvant T-DM1 vs TH
În curs de recrutareFaza 2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
În curs de recrutareFaza 2
- University of California San Francisco, San Francisco
Generative AI Patient Education Module for Breast Oncology
În curs de recrutare
- University of California, San Francisco, San Francisco
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
În curs de recrutareFaza 3
- University of California San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco
E-Mindfulness Approaches for Living After Breast Cancer
În curs de recrutareFaza 3
- Kaiser Permanente-San Francisco, San Francisco
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
În curs de recrutareFaza 2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- UCSF Medical Center at Mission Bay, San Francisco
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
În curs de recrutareFaza 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Magnetic Resonance Imaging in Radiotherapy for Breast Cancer
În curs de recrutareStudiu observațional
- University of California, San Francisco, San Francisco
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
În curs de recrutareFaza 3
- University of California at San Francisco, San Francisco
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
În curs de recrutareFaza 2
- University of California San Francisco (UCSF), San Francisco
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
În curs de recrutareFaza 2
- UCSF Medical Center-Mission Bay/Benioff Children's Hospital, San Francisco
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
În curs de recrutareFaza 2
- University of California San Francisco, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
În curs de recrutare
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
În curs de recrutareFaza 3
- California Pacific Medical Center-Pacific Campus, San Francisco
- Kaiser Permanente-San Francisco, San Francisco
Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction
În curs de recrutareStudiu observațional
- University of California, San Francisco
Microbiome and Association With Implant Infections
În curs de recrutareFaza 2
- University of California, San Francisco, San Francisco
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Kaiser Permanente-San Francisco, San Francisco
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
În curs de recrutareFaza 2
- University of California San Francisco (Data collection only), San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
În curs de recrutareFaza 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
În curs de recrutareFaza 1
- University of California San Francisco, San Francisco
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
În curs de recrutare
- UCSF Breast Care Center, San Francisco
Patient Care Outreach, Navigation, Technology and Support 2.0
În curs de recrutare
- Zuckerberg San Francisco General Hospital, San Francisco
- University of California, San Francisco, San Francisco
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, San Francisco
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
În curs de recrutareStudiu observațional
- UCSF Breast Care Center, San Francisco
Studii pentru Cancer de sân în alte orașe
- New York City, NY136 studii
- Houston, TX126 studii
- Boston, MA112 studii
- Nashville, TN81 studii
- Los Angeles, CA73 studii
- Edison, NJ68 studii
- St. Louis, MO64 studii
- Queens, NY64 studii
- Durham, NC64 studii
- Chicago, IL59 studii
- Philadelphia, PA56 studii
- Dallas, TX55 studii
Alte studii în San Francisco
- Cancer de prostată45 studii
- Cancer pulmonar cu celule non-pătrate36 studii
- Cancer (toate tipurile)35 studii
- Insuficiență cardiacă29 studii
- Cancer metastatic28 studii
- Cancer pulmonar22 studii
- Melanom22 studii
- Cancer pancreatic20 studii
- Cancer ovarian19 studii
- Cancer colorectal18 studii
- Boli cardiovasculare18 studii
- Glioblastom17 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.